It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PRTA’s FA Score shows that 0 FA rating(s) are green whileZG’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PRTA’s TA Score shows that 5 TA indicator(s) are bullish while ZG’s TA Score has 7 bullish TA indicator(s).
PRTA (@Biotechnology) experienced а +17.86% price change this week, while ZG (@Internet Software/Services) price change was +4.90% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.
The average weekly price growth across all stocks in the @Internet Software/Services industry was +2.42%. For the same industry, the average monthly price growth was +6.63%, and the average quarterly price growth was +9.54%.
PRTA is expected to report earnings on Aug 07, 2025.
ZG is expected to report earnings on Jul 31, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Internet Software/Services (+2.42% weekly)Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.
PRTA | ZG | PRTA / ZG | |
Capitalization | 291M | 11.2B | 3% |
EBITDA | -137.71M | 104M | -132% |
Gain YTD | -60.939 | -2.032 | 2,998% |
P/E Ratio | N/A | 128.21 | - |
Revenue | 138M | 1.95B | 7% |
Total Cash | 418M | 2.81B | 15% |
Total Debt | 10.2M | 1.83B | 1% |
PRTA | ZG | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 86 | |
SMR RATING 1..100 | 90 | 90 | |
PRICE GROWTH RATING 1..100 | 96 | 48 | |
P/E GROWTH RATING 1..100 | 94 | 100 | |
SEASONALITY SCORE 1..100 | 45 | 39 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PRTA's Valuation (56) in the Biotechnology industry is in the same range as ZG (79) in the Information Technology Services industry. This means that PRTA’s stock grew similarly to ZG’s over the last 12 months.
ZG's Profit vs Risk Rating (86) in the Information Technology Services industry is in the same range as PRTA (100) in the Biotechnology industry. This means that ZG’s stock grew similarly to PRTA’s over the last 12 months.
ZG's SMR Rating (90) in the Information Technology Services industry is in the same range as PRTA (90) in the Biotechnology industry. This means that ZG’s stock grew similarly to PRTA’s over the last 12 months.
ZG's Price Growth Rating (48) in the Information Technology Services industry is somewhat better than the same rating for PRTA (96) in the Biotechnology industry. This means that ZG’s stock grew somewhat faster than PRTA’s over the last 12 months.
PRTA's P/E Growth Rating (94) in the Biotechnology industry is in the same range as ZG (100) in the Information Technology Services industry. This means that PRTA’s stock grew similarly to ZG’s over the last 12 months.
PRTA | ZG | |
---|---|---|
RSI ODDS (%) | 3 days ago73% | N/A |
Stochastic ODDS (%) | 3 days ago77% | 3 days ago72% |
Momentum ODDS (%) | N/A | 3 days ago78% |
MACD ODDS (%) | 3 days ago76% | 3 days ago73% |
TrendWeek ODDS (%) | 3 days ago79% | 3 days ago75% |
TrendMonth ODDS (%) | 3 days ago88% | 3 days ago76% |
Advances ODDS (%) | 3 days ago75% | 5 days ago79% |
Declines ODDS (%) | 13 days ago87% | 18 days ago79% |
BollingerBands ODDS (%) | 3 days ago74% | 3 days ago71% |
Aroon ODDS (%) | 3 days ago87% | 3 days ago72% |
A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with RCKT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then RCKT could also see price increases.
Ticker / NAME | Correlation To PRTA | 1D Price Change % | ||
---|---|---|---|---|
PRTA | 100% | +6.92% | ||
RCKT - PRTA | 54% Loosely correlated | +10.65% | ||
SVRA - PRTA | 46% Loosely correlated | +2.52% | ||
DNLI - PRTA | 44% Loosely correlated | +3.38% | ||
KRYS - PRTA | 40% Loosely correlated | +3.26% | ||
RVMD - PRTA | 39% Loosely correlated | +2.26% | ||
More |
A.I.dvisor indicates that over the last year, ZG has been closely correlated with Z. These tickers have moved in lockstep 100% of the time. This A.I.-generated data suggests there is a high statistical probability that if ZG jumps, then Z could also see price increases.